Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 12, 2026 10:00 AM EST